Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian B Sheitman

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 30, 2003
A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trialLinmarie Sikich, Robert M Hamer, Robert A Bashford, et al.
North Carolina Medical Journal|July 12, 2018
A Model of Enhanced Primary Care for Patients with Severe Mental IllnessJacob Perrin, Brie Reimann, Jeff Capobianco, et al.
Administration and Policy in Mental Health|June 5, 2013
Examining the relationship between adjunctive psychotherapy use and antipsychotic persistence and hospitalizationChi-Chuan Wang, Matthew L Maciejewski, Jaya K Rao, et al.
Journal of Psychosocial Nursing and Mental Health Services|December 15, 2005
Implementing a smoking ban in an acute psychiatric admissions unitLinda S Matthews, Beth Diaz, Paula Bird, et al.
The American Journal of Psychiatry|August 6, 2003
Clozapine as a first treatment for schizophreniaMargaret G Woerner, Delbert G Robinson, Jose Ma J Alvir, et al.
Schizophrenia Research|April 6, 2004
Secretin for refractory schizophreniaBrian B Sheitman, Michael B Knable, L Fredrik Jarskog, et al.
Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care|September 30, 2022
Clozapine Reduces Recurrent Suicidal and Self-Injurious Behavior in Treatment-Refractory Incarcerated IndividualsTheodore R Zarzar, David L Rosen, James P Mayo, et al.
Psychiatric Services (Washington, D.C.)|January 30, 2009
Integrating forensically and civilly committed adult inpatients in a treatment mall program at a state hospitalSteven L Webster, Brian B Sheitman, Peter N Barboriak, et al.
The Journal of the American Academy of Psychiatry and the Law|February 21, 2019
Clozapine Reduces Self-Injurious Behavior in a State Prison PopulationTheodore R Zarzar, Terri L Catlett, Maria G O'Connell, et al.
Pharmacological Research|February 3, 2005
Identification of a naturally occurring 21 bp deletion in alpha 2c noradrenergic receptor gene and cognitive correlates to antipsychotic treatmentVincenzo De Luca, John B Vincent, Daniel J Müller, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 30, 2003
A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trialLinmarie Sikich, Robert M Hamer, Robert A Bashford, et al.
North Carolina Medical Journal|July 12, 2018
A Model of Enhanced Primary Care for Patients with Severe Mental IllnessJacob Perrin, Brie Reimann, Jeff Capobianco, et al.
Administration and Policy in Mental Health|June 5, 2013
Examining the relationship between adjunctive psychotherapy use and antipsychotic persistence and hospitalizationChi-Chuan Wang, Matthew L Maciejewski, Jaya K Rao, et al.
Journal of Psychosocial Nursing and Mental Health Services|December 15, 2005
Implementing a smoking ban in an acute psychiatric admissions unitLinda S Matthews, Beth Diaz, Paula Bird, et al.
The American Journal of Psychiatry|August 6, 2003
Clozapine as a first treatment for schizophreniaMargaret G Woerner, Delbert G Robinson, Jose Ma J Alvir, et al.
Schizophrenia Research|April 6, 2004
Secretin for refractory schizophreniaBrian B Sheitman, Michael B Knable, L Fredrik Jarskog, et al.
Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care|September 30, 2022
Clozapine Reduces Recurrent Suicidal and Self-Injurious Behavior in Treatment-Refractory Incarcerated IndividualsTheodore R Zarzar, David L Rosen, James P Mayo, et al.
Psychiatric Services (Washington, D.C.)|January 30, 2009
Integrating forensically and civilly committed adult inpatients in a treatment mall program at a state hospitalSteven L Webster, Brian B Sheitman, Peter N Barboriak, et al.
The Journal of the American Academy of Psychiatry and the Law|February 21, 2019
Clozapine Reduces Self-Injurious Behavior in a State Prison PopulationTheodore R Zarzar, Terri L Catlett, Maria G O'Connell, et al.
Pharmacological Research|February 3, 2005
Identification of a naturally occurring 21 bp deletion in alpha 2c noradrenergic receptor gene and cognitive correlates to antipsychotic treatmentVincenzo De Luca, John B Vincent, Daniel J Müller, et al.
Pageof 3